MAPT and Alzheimer disease: Meanwhile, application of a selective 5-HT2CR antagonist, RS-102221, can prevent Tau hyperphosphorylation and improve hippocampal LTP and spatial memory in stressed mice [222], suggesting that blockade of 5-HT2CR may attenuate cognitive deficits in AD.